[1] 赵增虎,刘俊堂,范青建. 放射性肝损伤研究及防治进展. 现代肿瘤医学,2011,19(10):2110-2113. [2] Kennedy AS,Sangro B.Nonsurgical treatment for localized hepatocellular carcinoma. Curr Oncol Rep,2014,16(3):373-380. [3] 王华,魏伟.肝纤维化与细胞因子的关系.中国药理学通报,2002,18(2):132-136. [4] Christiansen H,Sheikh N,Saile B,et al.X-irradiation in rat liver:consequent upregulation of hepcidin and downregulation of hemojuvelin and ferroportin-1 gene expression. Radiology,2007,242(1):189-197. [5] 赵水喜,郑静晨,曹京旭,等. 早期放射性肝损伤的CT影像和生化改变. 肿瘤防治研究,2006,33(5):361-363. [6] Dawson LA,Normolle D,Balter JM,et al.Analysis of radiation-induced liver disease using the Lyman NTCP model.Int J Radiat Oncol Biol Phys,2002,53(4):810-821. [7] 曾昭冲. 原发性肝癌放射治疗的争论与共识. 临床肿瘤学杂志,2008,13(2):97-104. [8] 陈万青,郑荣寿,张思维. 2012年中国恶性肿瘤发病和死亡分析.中国肿瘤,2016,25(1):1-8. [9] Kondo Y,Kimura O,Shimosegawa T.Radiation therapy has been shown to be adaptable for various stages of hepatocellular carcinoma.World J Gastroenterol,2015,21(1):94-101. [10] Cheng JC,Liu HS,Wu JK,et al.Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease. Int J Radiat Oncol Biol Phys,2005,62(4):1150-1156. [11] 董天明,安宁豫. 放射性肝损伤影像学研究现状. 中国医学科学院学报,2013,35(6):694-697. [12] Trotti A,Byhardt R,Stetz J,et al.Common toxicity criteria:version 2.0. An improved reference for grading the acute effects of cancer treatment:impact on radiotherapy. Int J Radiat Oncol Biol Phys,2000,47(1):13-47. [13] Wu DH,Liu L,Chen LH.Therapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol,2004,10(15):2184-2189. [14] 梁世雄,蒋国梁,朱小东,等. 原发性肝癌三维适形放疗后放射性肝病的影响因素. 中华放射肿瘤学杂志,2005,14(4):284-288. |